Chandan Healthcare Limited is launching its IPO from February 10, 2025, to February 12, 2025, with a price band set between ₹151 and ₹159 per share. The IPO comprises a total issue size of 67,52,000 shares, aggregating up to ₹107.36 crore, including a fresh issue of 44,52,064 shares worth ₹70.79 crore and an offer for sale of 22,99,936 shares amounting to ₹36.57 crore.
The face value of each share is ₹10, and the minimum lot size for retail investors is 800 shares, requiring an investment of ₹1,27,200. High Net Worth Individuals (HNIs) must apply for a minimum of two lots, amounting to 1,600 shares at ₹2,54,400. The IPO follows a book-built issue format and will be listed on the NSE SME platform.
The tentative IPO timeline includes the basis of allotment on February 13, 2025, followed by the initiation of refunds and credit of shares to Demat accounts on February 14, 2025. The listing of Chandan Healthcare shares is expected on February 17, 2025.
Chandan Healthcare Limited, incorporated in September 2003, operates diagnostic centers across North India, offering pathology and radiology testing services. As of December 31, 2024, the company manages a flagship laboratory, seven central laboratories, and twenty-six satellite centers, along with over three hundred collection centers spanning more than twenty-three cities in Uttar Pradesh and over nineteen in Uttarakhand.
The company provides a comprehensive test menu with 1,496 tests across various specialties, including 481 routine pathology tests in basic biochemistry and haematology, and 1,015 specialized tests such as immunohistopathology and molecular pathology. Additionally, it offers 545 radiology tests, covering x-rays, ultrasonography, CT scans, MRI scans, and specialized CT procedures.
Its radiology facilities include eleven CT scanners and four MRI machines. As of December 31, 2024, Chandan Healthcare employs fifteen radiologists, twenty-three pathologists, and over 161 other qualified professionals. The company primarily provides diagnostic services, along with ad hoc sales of consumables like X-ray films and reagents. Its subsidiary, Chandan Pharmacy Limited, operates medical stores offering a range of pharmaceutical products.
Chandan Healthcare also offers preventive and wellness services, as well as home collection services for patient convenience.
IPO stands for "Initial Public Offering." It's the process through which a privately-held company becomes publicly traded by offering its shares to the general public and listing them on a stock exchange for trading. This allows the company to raise capital from investors and grants individuals and institutions the opportunity to invest in and own a portion of the company.
The life cycle of an IPO, or Initial Public Offering, begins with a company's decision to go public. It involves hiring underwriters, registering with regulatory authorities, determining the IPO price, marketing to investors, and the subscription period where investors place orders for shares. After allocation and listing, shares become publicly tradable, and the company enters the secondary market. Ongoing reporting and corporate governance are crucial as the company continues to operate as a publicly-traded entity. The IPO aims to raise capital for growth and provides investors with opportunities to trade shares in the company.
An IPO (Initial Public Offering) is when a private company goes public by selling shares to the public. Investors buy these shares, giving them ownership in the company. It's a way for companies to raise capital and expand. The process involves underwriters, regulatory filings, setting the IPO price, and marketing to investors. After the IPO, shares can be traded on a stock exchange. IPOs offer opportunities and risks, so investors should research and consider carefully.
"Upcoming IPOs" refers to initial public offerings that have been announced by private companies but have not yet occurred. These are companies that plan to go public in the near future by issuing shares to the public and listing them on a stock exchange. Investors often keep an eye on upcoming IPOs as they represent opportunities to invest in companies at their early stages of public trading, potentially capturing growth potential. These offerings are typically accompanied by significant media and investor attention as they approach their launch dates.